Counterfeiting in performance- and image-enhancing drugs

Michael R. Graham; Paul Ryan; Julien S. Baker; Bruce Davies; Non-Eleri Thomas; Stephen-Mark Cooper; Peter Evans; Sue Easmon; Christopher J. Walker; David Cowan; Andrew T. Kicman

doi:10.1002/dta.30

Counterfeiting in performance- and image-enhancing drugs

Michael R. Graham, Paul Ryan, Julien S. Baker, Bruce Davies, Non-Eleri Thomas, Stephen-Mark Cooper, Peter Evans, Sue Easmon, Christopher J. Walker, David Cowan, Andrew T. Kicman

Research output: Contribution to journal › Article › peer-review

66 Citations (Scopus)

Abstract

The current drastic escalation in obesity may be contributing to the exponential rise in drugs used for image enhancement. Drugs such as anabolic-androgenic steroids (AAS) are perceived as a viable method of achieving a perfect physique. They are also the most widely abused drugs in sport. The Internet has encouraged the abuse of expensive drugs, particularly human growth hormone (hGH), resulting in increased importation for personal use. The substantial increase in this market has opened up avenues for counterfeiting, estimated as a multi-million pound business. The acute adverse effects from contaminated vials may result in a variety of pathologies including communicable diseases. In 2007, in the UK, a series of intramuscular abscesses, requiring surgical treatment, led us to study samples obtained from the underground market. The analysis of 38 parenteral samples and 19 oral samples of tablets was performed by a World Anti-Doping Agency (WADA) accredited laboratory, in an attempt to establish the extent of available counterfeit products. Fifty-three per cent (20) of the injectable AAS esters and 21% (4) of the oral tablets were counterfeit. Culture and sensitivity revealed the presence of skin commensal organisms, which may have contributed to the development of the abscesses. Users of AAS and hGH for sport, including bodybuilding, are currently risking their health because of counterfeit and poorly controlled products. Copyright (C) 2009 John Wiley & Sons, Ltd.

Original language	English
Pages (from-to)	135 - 142
Number of pages	8
Journal	Drug Testing And Analysis
Volume	1
Issue number	3-4
DOIs	https://doi.org/10.1002/dta.30
Publication status	Published - Mar 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/dta.30

Cite this

@article{591e37b9e97f4230b1c8c5e789752d41,

title = "Counterfeiting in performance- and image-enhancing drugs",

abstract = "The current drastic escalation in obesity may be contributing to the exponential rise in drugs used for image enhancement. Drugs such as anabolic-androgenic steroids (AAS) are perceived as a viable method of achieving a perfect physique. They are also the most widely abused drugs in sport. The Internet has encouraged the abuse of expensive drugs, particularly human growth hormone (hGH), resulting in increased importation for personal use. The substantial increase in this market has opened up avenues for counterfeiting, estimated as a multi-million pound business. The acute adverse effects from contaminated vials may result in a variety of pathologies including communicable diseases. In 2007, in the UK, a series of intramuscular abscesses, requiring surgical treatment, led us to study samples obtained from the underground market. The analysis of 38 parenteral samples and 19 oral samples of tablets was performed by a World Anti-Doping Agency (WADA) accredited laboratory, in an attempt to establish the extent of available counterfeit products. Fifty-three per cent (20) of the injectable AAS esters and 21% (4) of the oral tablets were counterfeit. Culture and sensitivity revealed the presence of skin commensal organisms, which may have contributed to the development of the abscesses. Users of AAS and hGH for sport, including bodybuilding, are currently risking their health because of counterfeit and poorly controlled products. Copyright (C) 2009 John Wiley & Sons, Ltd.",

author = "Graham, {Michael R.} and Paul Ryan and Baker, {Julien S.} and Bruce Davies and Non-Eleri Thomas and Stephen-Mark Cooper and Peter Evans and Sue Easmon and Walker, {Christopher J.} and David Cowan and Kicman, {Andrew T.}",

year = "2009",

month = mar,

doi = "10.1002/dta.30",

language = "English",

volume = "1",

pages = "135 -- 142",

journal = "Drug Testing And Analysis",

issn = "1942-7611",

publisher = "John Wiley and Sons Ltd",

number = "3-4",

}

TY - JOUR

T1 - Counterfeiting in performance- and image-enhancing drugs

AU - Graham, Michael R.

AU - Ryan, Paul

AU - Baker, Julien S.

AU - Davies, Bruce

AU - Thomas, Non-Eleri

AU - Cooper, Stephen-Mark

AU - Evans, Peter

AU - Easmon, Sue

AU - Walker, Christopher J.

AU - Cowan, David

AU - Kicman, Andrew T.

PY - 2009/3

Y1 - 2009/3

N2 - The current drastic escalation in obesity may be contributing to the exponential rise in drugs used for image enhancement. Drugs such as anabolic-androgenic steroids (AAS) are perceived as a viable method of achieving a perfect physique. They are also the most widely abused drugs in sport. The Internet has encouraged the abuse of expensive drugs, particularly human growth hormone (hGH), resulting in increased importation for personal use. The substantial increase in this market has opened up avenues for counterfeiting, estimated as a multi-million pound business. The acute adverse effects from contaminated vials may result in a variety of pathologies including communicable diseases. In 2007, in the UK, a series of intramuscular abscesses, requiring surgical treatment, led us to study samples obtained from the underground market. The analysis of 38 parenteral samples and 19 oral samples of tablets was performed by a World Anti-Doping Agency (WADA) accredited laboratory, in an attempt to establish the extent of available counterfeit products. Fifty-three per cent (20) of the injectable AAS esters and 21% (4) of the oral tablets were counterfeit. Culture and sensitivity revealed the presence of skin commensal organisms, which may have contributed to the development of the abscesses. Users of AAS and hGH for sport, including bodybuilding, are currently risking their health because of counterfeit and poorly controlled products. Copyright (C) 2009 John Wiley & Sons, Ltd.

AB - The current drastic escalation in obesity may be contributing to the exponential rise in drugs used for image enhancement. Drugs such as anabolic-androgenic steroids (AAS) are perceived as a viable method of achieving a perfect physique. They are also the most widely abused drugs in sport. The Internet has encouraged the abuse of expensive drugs, particularly human growth hormone (hGH), resulting in increased importation for personal use. The substantial increase in this market has opened up avenues for counterfeiting, estimated as a multi-million pound business. The acute adverse effects from contaminated vials may result in a variety of pathologies including communicable diseases. In 2007, in the UK, a series of intramuscular abscesses, requiring surgical treatment, led us to study samples obtained from the underground market. The analysis of 38 parenteral samples and 19 oral samples of tablets was performed by a World Anti-Doping Agency (WADA) accredited laboratory, in an attempt to establish the extent of available counterfeit products. Fifty-three per cent (20) of the injectable AAS esters and 21% (4) of the oral tablets were counterfeit. Culture and sensitivity revealed the presence of skin commensal organisms, which may have contributed to the development of the abscesses. Users of AAS and hGH for sport, including bodybuilding, are currently risking their health because of counterfeit and poorly controlled products. Copyright (C) 2009 John Wiley & Sons, Ltd.

U2 - 10.1002/dta.30

DO - 10.1002/dta.30

M3 - Article

SN - 1942-7611

VL - 1

SP - 135

EP - 142

JO - Drug Testing And Analysis

JF - Drug Testing And Analysis

IS - 3-4

ER -

Counterfeiting in performance- and image-enhancing drugs

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this